Adynxx's Cash & cash equivalent grew by 1279.17 % in the Q3 2019 sequentially, faster than Current Liabilities, this led to improvement in Adynxx's Quick Ratio to 0.02, Quick Ratio remained below Adynxx, Inc. average.

Within Medical Equipment & Supplies industry 198 other companies have achieved higher Quick Ratio than Adynxx in third quarter 2019. While Quick Ratio total ranking has improved so far during the Q3 2019 to 4865, from total ranking in the second quarter 2019 at 4927.

Explain Quick Ratio?
How much Cash & cash equivalents ADYX�s has?
What are ADYX�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADYX Quick Ratio	(Sep 30 2019) Q3	(Jun 30 2019) Q2	(Mar 31 2019) Q1	(Dec 31 2018) Q4	(Sep 30 2018) Q3
Y / Y Current Liabilities Change	345.35 %	255.71 %	-87.09 %	-92.81 %	-81.42 %
Y / Y Cash & cash equivalent Change	-81.19 %	-99.78 %	2.93 %	-56.13 %	-16.43 %
Quick Ratio MRQ	0.02	0	0.58	1.37	0.57
ADYX's Total Ranking	# 4865	# 4927	# 4925	# 498	# 797
Seq. Current Liabilities Change	20.38 %	323.07 %	96.88 %	-55.58 %	-3.85 %
Seq. Cash & cash equivalent Change	1279.17 %	-98.48 %	-16.22 %	7.22 %	-84.03 %

Quick Ratio third quarter 2019 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 199
Healthcare Sector	# 948
Overall Market	# 4865

Quick Ratio Statistics
High	Average	Low
7.93	2.11	0
(Mar 31 2019)		(Jun 30 2019)

Financial Statements
Adynxx's Current Liabilities	$ 14 Millions	Visit ADYX's Balance sheet
Adynxx's Cash & cash equivalent	$ 0 Millions	Visit ADYX's Balance sheet
Source of ADYX's Sales		Visit ADYX's Sales by Geography

Cumulative Adynxx's Quick Ratio

ADYX's Quick Ratio for the trailling 12 Months

ADYX Quick Ratio	(Sep 30 2019) 12 Months	(Jun 30 2019) 12 Months	(Mar 31 2019) 12 Months	(Dec 31 2018) 12 Months	(Sep 30 2018) 12 Months
Y / Y Current Liabilities TTM Growth	-36.82 %	-68.94 %	-86.22 %	-61.2 %	-33.21 %
Y / Y Cash & cash equivalent TTM Growth	-79.47 %	-72.31 %	58.65 %	46.56 %	50.94 %
Quick Ratio TTM	0.13	0.28	1.56	0.57	0.4
Total Ranking TTM	# 4776	# 4619	# 1887	# 4648	# 4781
Seq. Current Liabilities TTM Growth	57.39 %	79.18 %	-63.72 %	-38.26 %	-22.61 %
Seq. Cash & cash equivalent TTM Growth	-27.21 %	-67.68 %	0.28 %	-12.97 %	-1.82 %

Quick ratio ranking by company, industry and sector >> Back to ADYX Financial Strength Comparisons >> Go to Compare ADYX Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q3 2019 to $13.80 millions, cumulative Quick Ratio decreased to 0.13 below the Adynxx, Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 203 other companies have achieved higher Quick Ratio than Adynxx. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2019 from 4619 to 4776.

Explain Quick Ratio?
How much Cash & cash equivalents ADYX�s has?
What are ADYX�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 204
Healthcare Sector	# 912
Within the Market	# 4776

trailing twelve months Quick Ratio Statistics
High	Average	Low
4.79	2.03	0.11
(Dec 31 2014)		(Mar 31 2018)

Companies with similar Quick Ratio in the quarter ending Sep 30 2019, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2019 MRQ Cash & cash equivalent	Sep 30 2019 MRQ Current Liabilities
Boston Scientific Corporation	0.07	$ 277.000 Millions	$ 4,254.000 Millions
H cyte Inc	0.05	$ 0.368 Millions	$ 7.268 Millions
Imaging Diagnostic Systems Inc	0.05	$ 0.040 Millions	$ 0.882 Millions
Prolung Inc	0.04	$ 0.040 Millions	$ 0.908 Millions
Premier Air Charter Holdings Inc	0.04	$ 0.002 Millions	$ 0.052 Millions
Vycor Medical Inc	0.04	$ 0.099 Millions	$ 2.353 Millions
Sanara Medtech Inc	0.04	$ 0.161 Millions	$ 4.035 Millions
Vaso Corporation	0.04	$ 1.343 Millions	$ 34.622 Millions
Star Equity Holdings Inc	0.04	$ 1.673 Millions	$ 43.382 Millions
Remedent Inc	0.03	$ 0.085 Millions	$ 2.700 Millions
Sanuwave Health Inc	0.03	$ 0.403 Millions	$ 14.545 Millions
Petvivo Holdings Inc	0.03	$ 0.028 Millions	$ 1.072 Millions
Dynatronics Corporation	0.03	$ 0.375 Millions	$ 14.384 Millions
Adynxx, Inc.	0.02	$ 0.331 Millions	$ 13.797 Millions
Bone Biologics Corporation	0.02	$ 0.202 Millions	$ 11.632 Millions
Nuo Therapeutics Inc	0.01	$ 0.017 Millions	$ 1.278 Millions
Biotricity Inc	0.01	$ 0.073 Millions	$ 5.789 Millions
Therapeutic Solutions International Inc	0.01	$ 0.020 Millions	$ 1.960 Millions
Todos Medical Ltd	0.01	$ 0.012 Millions	$ 1.562 Millions
Vystar Corporation	0.01	$ 0.064 Millions	$ 9.724 Millions
Wearable Health Solutions, Inc.	0.01	$ 0.005 Millions	$ 0.839 Millions

Date modified: 2026-09-08T15:09:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.